Advancing Canine Health

GOLDEN RETRIEVER LIFETIME STUDY - DATA AND SAMPLES AVAILABLE FOR RESEARCH

The Golden Retriever Lifetime Study is a longitudinal study established in 2012 with a cohort of 3,044 dogs at full enrollment in 2015. Primary Study endpoints include lymphoma, hemangiosarcoma, high-grade mast cell tumors and osteosarcoma. Secondary Study endpoints cover a variety of diseases affecting the breed, including other cancers. Now in its 10th year, the Study provides a rich data set for researchers from universities, nonprofit and governmental organizations as well as private industry.

Dog owners and veterinarians are completing annual questionnaires, clinical exams and sample collection over each dog’s lifetime. These data and samples are now available for research questions in areas such as genetics, disease conditions, environmental factors, nutrition and behavior to improve canine health. While the Study was established to determine risk factors for major cancers, the data and samples can be used to explore many other aspects of canine health.
APPLY FOR DATA & SAMPLES

PROPOSAL APPLICATION FLOWCHART

Below you will find a flowchart that describes the process for a typical university-based research proposal.
1. Feasibility Review, Researcher reviews available data/samples to ensure project is feasible, Researcher submits project proposal via the submission form, Researcher responds to proposal questions as needed, Researcher receives proposal decision from Morris Animal Foundation (Turnaround Time: 2-3 weeks on average from proposal submission); 2. Materials Transfer: Materials Transfer Agreement is completed and signed by all parties, Data and/or samples are transferred from Morris Animal Foundation (Turnaround Time: 4-6 weeks from Material Transfer Agreement Completion); 3. Reporting, Status report completed by researcher and submitted to Morris Animal Foundation every 6 months, Include Morris Animal Foundation acknowledgment in publication, See FAQ for acknowledgment wording, Publish results and send citation to Morris Animal Foundation

AVAILABLE DATA

Below you will find the demographics that will be shared with you.
  • Dog ID
  • Name
  • Study year
  • Date of birth
  • Enrollment date
  • Anniversary date
  • Study status
  • Enrollment end date (if applicable)
  • Sex status
  • Coat color
  • State of residence
Annual Owner Questionnaire contains information on each dog’s lifestyle, travel history, reproductive history, physical activity, over-the-counter medications, at-home dental care, grooming history, diet and feeding practices, environment, living conditions and exposures, flea/tick and heartworm preventives, and a behavioral questionnaire (C-BARQ).

Annual Veterinarian Questionnaire includes data on each dog’s medical history, physical exam findings including height at withers, weight and body condition score, a map of superficial masses, vaccination history and prescription medication history.

DATA DASHBOARD

AVAILABLE SAMPLES

For academic, nonprofit and government organizations, the following samples are available at this time. (The Foundation reserves the right to revise sample access as needed.)
SPECIMEN STORAGE CONDITIONS BANKED PRODUCT DISTRIBUTION AMOUNT VISIT COLLECTED
GENOMIC DNA -80 °C DNA ALIQUOTS ADJUSTED TO 100 NG/ ML 1-5 MG BASELINE
WHOLE BLOOD -80 °C 1 ML ALIQUOTS 250 ML NON-BASELINE VISITS
URINE -80 °C 1 ML ALIQUOTS 1 ML ALL ANNUAL VISITS
HAIR CLIPPING -20 °C 1 SAMPLE PER VISIT 1 SAMPLE ALL ANNUAL VISITS
NAIL CLIPPINGS -20 °C 1 SAMPLE PER VISIT 1 SAMPLE ALL ANNUAL VISITS
For potential industry partners, the following samples are available at this time. (The Foundation reserves the right to revise sample access as needed.)
SPECIMEN STORAGE CONDITIONS BANKED PRODUCT DISTRIBUTION AMOUNT VISIT COLLECTED
GENOMIC DNA -80 °C DNA ALIQUOTS ADJUSTED TO 100 NG/ ML 1-5 MG BASELINE
WHOLE BLOOD -80 °C 1 ML ALIQUOTS 250 ML NON-BASELINE VISITS
SERUM -80 °C 1 ML & 250 ML ALIQUOTS 250 ML ALL ANNUAL VISITS
URINE -80 °C 1 ML ALIQUOTS 1 ML ALL ANNUAL VISITS
FECES -80 °C 1 ML ALIQUOT PER VISIT DISCUSS WITH STUDY TEAM ALL ANNUAL VISITS
HAIR CLIPPING -20 °C 1 SAMPLE PER VISIT 1 SAMPLE ALL ANNUAL VISITS
NAIL CLIPPINGS -20 °C 1 SAMPLE PER VISIT 1 SAMPLE ALL ANNUAL VISITS

Frequently Asked Questions

What are the terms of the data use agreement?

The agreement details publication requirements and how the data can and cannot be used. Contact the Foundation with specific questions.

What form is the data in?

The data is sent as a .csv file.

What is the process?

Please refer to our Application Process Flowchart above.

Do I need to include an acknowledgment to the Foundation in any publications?

Acknowledgement: We would like to thank Morris Animal Foundation, its staff members and all participants in the Golden Retriever Lifetime Study, including the dog owners, their golden retrievers and the Study veterinarians who made this work possible.

Funding: The Golden Retriever Lifetime Study and this manuscript were made possible through financial support provided by the Morris Family Foundation, the Mark & Bette Morris Family Foundation, VCA, the V Foundation, Blue Buffalo Company, Petco Love, Zoetis, Antech Inc., Elanco, the Purina Institute, Orvis, the Golden Retriever Foundation, the Hadley and Marion Stuart Foundation, Mars Veterinary, generous private donors and the Flint Animal Cancer Center at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

What do the endpoint tiers mean?

Endpoint tiers are used to evaluate confidence in each cancer diagnosis.

CONFIDENCE TIER CATEGORY
DEFINITIVE

1
(MICROSCOPICALLY CONFIRMED)

POSITIVE HISTOLOGY OR CYTOLOGY REVIEWED BY A BOARDCERTIFIED PATHOLOGIST. FOR LYMPHOMA, FLOW CYTOMETRY OR PARR ACCEPTED
PRESUMPTIVE

2
(NOT MICROSCOPICALLY CONFIRMED)

DIRECT VISUALIZATION OR IMAGING WITHOUT MICROSCOPIC CONFIRMATION. FOR LYMPHOMA, IN-HOUSE CYTOLOGY
PRESUMPTIVE 3
(CLINICAL SUSPICION)
CLINICAL DIAGNOSIS ONLY

 

GOLDEN RETRIEVER LIFETIME STUDY JOURNAL ARTICLES

APPROVED APPLICATIONS

PI NAME AFFILIATION TOPIC
Ruple, Audrey Purdue Predictors of compliance following baseline
Boyko, Adam Embark Coefficient of inbreeding and reproductive outcomes
Jeffry, Unity Texas A&M Changes in routine bloodwork over time
Kubas, Elizabeth Ethos Intestinal parasite prevalence at baseline, risk factors, and clinicopathologic changes
Stern, Josh UC Davis Taurine deficiency
Wood, Geoffrey Guelph Blood microRNA profiling for early lymphoma detection
Raffan, Eleanor Cambridge Genetics of obesity
Loy Son, Natasha Ethos Comparison of clinicopathologic data in juvenile golden retrievers in relation to body condition
Wingerd, Molly Ethos Raw diet and blood biochemistry changes
Luetchke, Ross Wisconsin Lymphoma and proximity to environmental pollutants
Miller, Chris CU Denver Fecal microbiome and obesity
Sawatzki, Kaitlin Tufts Optimizing a COVID PCR test
Raditic, Donna & Bartges, Joseph UGA Advanced glycation end products and diet, aging, obesity
Rao, Sangeeta CSU Infectious disease in young dogs and antimicrobial use